This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Europe

ONLINE REGISTRATION CLOSES IN:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered as a Hybrid Event, 7 - 9 June, 2022
Live In-Person Event: 7 - 9 June, Postillion Hotel AmsterdamDigital Experience: All Sessions Livestreamed 7 - 9 June

Shohei Koide, PhD
Professor of Biologics Design, Department of Biochemistry and Molecular Pharmacology at New York University School of Medicine

Profile

Shohei Koide, Ph.D. is a synthetic protein scientist. His research integrates mechanistic biochemistry and directed evolution to create highly functional but still simple proteins. He is the inventor of the FN3 Monobody technology. He has made important contribution to establishing synthetic antibody technologies and the application of synthetic binding proteins to mechanistic biology, medicine and chemistry.

Agenda Sessions

  • Pushing the Envelope of Synthetic Binding Proteins with Monobodies

    10:20